Services

Scoped to What You
Actually Need.

We audit what you already have, develop only what the DEA genuinely requires, and navigate every section of the federal application — so you don’t pay for work your existing state compliance already covers.

Dispensaries
Upcoming DEA Licensing
International / Export

SOP Gap Analysis

Which of your state SOPs already qualify for federal registration?

 

The DEA Final Order (21 CFR §1301.13(k)) was deliberately structured to accept state compliance infrastructure as satisfying federal requirements wherever possible. The Vantic SOP gap audit applies the §1301.13(k) safe harbour matrix to your specific SOP library.

Our engagement scope — and your fee — covers only the work in the red column below.

 

Green — your state SOPs already satisfy the DEA requirement

 

Amber — Vantic confirms minor federal supplement needed

 

Red — new federal SOP required; Vantic writes this

Section 5 SOP CategoryDEA Requirement (CFR)Safe Harbour ProvisionYour State SOPs Sufficient?Corresponding ResponsibilityVantic Action
Security21 CFR 1301.71–1301.76§1301.13(k)(10) — explicit full safe harbour✓ Yes — completelyOperator confirms state-approved security plan on file Vantic reviews and confirms state security approval
Storage21 CFR 1301.71–1301.76§1301.13(k)(10) — security = state law✓ YesOperator provides state storage SOP documentation Vantic verifies existing state storage SOP
Destruction & Disposal21 CFR Part 1317§1301.13(k)(9) — explicit full safe harbour✓ Yes — completelyOperator provides current state-compliant destruction SOP Vantic confirms state SOP satisfies §1301.13(k)(9)
Dispensing21 CFR Part 1306§1301.13(k)(5) — state certification sufficient✓ YesOperator provides patient certification process documentation Vantic provides §825(c) federal warning label wording
Labeling & Packaging21 CFR Part 1302§1301.13(k)(8) — state labels exempt⚠ Mostly yesOperator provides current product label templates for review Vantic confirms §825(c) warning added
Inventory Records21 CFR 1304.03–1304.11§1301.13(k)(4) — state records accepted✓ Yes (Metrc/BioTrack)Operator confirms seed-to-sale system in active use Vantic confirms biennial inventory date and system coverage
Receiving Records21 CFR Part 1304§1301.13(k)(4) — state records accepted✓ YesOperator provides state receiving / transfer records SOP Existing state records sufficient
Ordering Records21 CFR 1301.74; Part 1305§1301.13(k)(4) — accepted to max extent✓ Largely yesOperator provides state ordering documentation and purchase records Vantic verifies seed-to-sale system coverage
Theft & Loss Reporting21 CFR 1301.76(b) — no state safe harbourNo safe harbour exists✕ State SOP insufficientOperator provides DEA Field Division contact details🔴 Vantic drafts new federal DEA theft/loss SOP
Supplier DEA Verification§1301.13(k) — new obligation post Apr 28, 2026No state equivalent exists✕ Entirely new obligationOperator provides current supplier list; Vantic verifies DEA registration status🔴 Vantic drafts new supplier DEA verification SOP
INCB Treaty ReportingArts. 19 & 20 Single ConventionFederal/treaty level only — no state equivalent⚠ No state SOP covers thisOperator ensures inventory records maintained with sufficient detail Vantic confirms record structure for DEA INCB reporting

Regulatory Reference

DEA Final Order — Key Provisions for Dispensary Registration

 
Based on the DEA Final Order effective April 28, 2026. Individual applicability varies by state and operator type. This is not legal advice. Vantic conducts an individual regulatory audit for each client prior to application submission.
CFR SectionProvisionRegulatory RequirementCorresponding ResponsibilityImpact Classification
§1301.13(k)(3)State License Scope & Auto-SuspensionDEA registration is capped by your state license. If your state license lapses, DEA registration suspends immediately — no grace period.Operator maintains active state license at all times; Vantic recommends 90-day advance renewal monitoring.⚠ Watch Item
§1301.13(k)(4)Reports, Records & Order FormsDEA must accept state-required reports and records to the maximum extent possible. Metrc/BioTrack systems satisfy federal recordkeeping in most cases.Operator confirms seed-to-sale system is active and records are current.✓ State Records Sufficient
§1301.13(k)(5)Dispensing — Patient CertificationState patient certification is sufficient to authorise dispensing. No separate federal prescription or DEA Form 222 required.Operator provides state patient certification documentation; Vantic adds §825(c) warning language.✓ State Certification Sufficient
§1301.13(k)(8)Labeling, Packaging & SealingState-compliant labels are fully sufficient. Only federal addition is the 21 U.S.C. §825(c) warning.Operator provides current product label templates; Vantic confirms §825(c) wording is added.⚠ One Label Addition
§1301.13(k)(9)Disposal & DestructionPart 1317 federal disposal rules are entirely overridden. State-approved destruction procedures are the sole governing standard.Operator provides state-compliant destruction SOP; no additional federal work required.✓ Full Safe Harbour
§1301.13(k)(10)Physical Security RequirementsIf your facility meets state security law, it meets the federal DEA security standard. No additional federal security SOP required under any circumstances.Operator provides state-approved security plan; Vantic confirms it satisfies §1301.13(k)(10).✓ Strongest Safe Harbour
§1301.76(b)Theft & Loss ReportingNo state safe harbour. DEA registrants must report directly to DEA Field Division and submit DEA Form 106. State board notification alone does NOT satisfy this.Vantic develops new federal SOP: DEA notification channels, Form 106 procedure, and timelines.🔴 New Federal SOP
§1301.13(k) Due DiligenceSupplier DEA Registration VerificationBrand new obligation post April 28, 2026. Every supplier must be verified as holding a valid DEA registration number before product acquisition.Operator provides supplier list; Vantic develops new SOP covering pre-acquisition verification.🔴 Entirely New SOP

Upcoming DEA License Categories

Every DEA Registration Pathway Opening Under Schedule III

 
DEA Confirmed — May 2026“In the coming weeks, an updated ‘Medical Marijuana Manufacturer,’ ‘Medical Marijuana Bulk Manufacturer (grower/cultivator),’ ‘Medical Marijuana Analytical Lab’ and ‘Medical Marijuana Distributor’ application will be available.” — DEA Diversion Control Division

Portal Open Now

 

Dispenser

Medical Marijuana Dispensary

The 60-day expedited window is open at mmapplication.diversion.dea.gov. File before June 27 to secure Safe Harbor protection and a 6-month review commitment.

  • DEA Form 224 via the dedicated dispensary portal
  • 2 new SOPs required: theft/loss reporting + supplier DEA verification
  • Safe Harbor protects ongoing operations during review
  • 280E relief applies from April 22, 2026

Portal Coming Soon

 

Bulk Manufacturer

Medical Marijuana Cultivator (Grower)

State-licensed cultivators are classified as manufacturers under federal law. A dedicated portal is confirmed coming imminently.

  • Dedicated cultivator portal confirmed — coming soon
  • Form 225 interim pathway available now
  • Requires nominal-price DEA crop purchase-and-resale SOP
  • Registration specifies permitted cultivation areas

Portal Coming Soon

 

Manufacturer

Medical Marijuana Manufacturer / Processor

Processors, extractors, and manufacturers converting medical cannabis into products. Most complex compliance obligations of all categories.

  • Dedicated manufacturer portal confirmed — coming soon
  • Nominal-price DEA crop purchase-and-resale SOP required
  • FDA cGMP (21 CFR 210/211) intersection for pharmaceutical-grade operators
  • EU-GMP alignment for operators targeting international export

Portal Coming Soon

 

Analytical Lab

Medical Marijuana Analytical Laboratory

State-licensed testing labs handling Schedule III medical cannabis samples now require DEA registration.

  • Dedicated lab portal confirmed — coming soon
  • Required to maintain legal possession of Schedule III cannabis for testing
  • Chain of custody SOPs require review for DEA compliance
  • Significant competitive advantage for labs that register early

Portal Coming Soon

 

Distributor

Medical Marijuana Distributor

State-licensed distributors moving medical cannabis between registered facilities must hold DEA registration. Early registration creates a structural supply-chain advantage.

  • Dedicated distributor portal confirmed — coming soon
  • All product movement between registered facilities requires distributor DEA registration
  • Supplier verification SOP critical for distributor operations
  • Positioned for interstate commerce once federal framework permits

International & Export Opportunities

DEA Registration Is the Foundation.
Export Markets Are the Opportunity.

 

Federal DEA registration as a manufacturer is the US gateway to international pharmaceutical-grade cannabis markets. Vantic’s principals have direct practitioner experience with the first US facilities authorised for DEA-licensed international cannabis export.

🌍

Medium-Term

EU Pharmaceutical Cannabis Markets

Germany, the Netherlands, Czech Republic, and the UK are active importers of pharmaceutical-grade cannabis. EU-GMP certification is the entry requirement. Vantic advises on both the EU-GMP gap and the DEA registration pathway simultaneously.

🦘

Medium-Term

Australia — TGA Import Pathway

Australia’s TGA is one of the most active import markets for medical cannabis products. GMP certification to a recognised standard is required. Vantic has advised on regulatory pathways into Australia.

✡️

Medium-Term

Israel — IMC-GMP Pathway

Israel operates one of the most mature medical cannabis import frameworks globally. The Israeli Medical Cannabis (IMC) program requires IMC-GMP certification. Vantic has advised on regulatory pathways into Israeli medical markets.

🔬

Near-Term

Clinical Research & API Supply

DEA-registered manufacturers can supply API cannabis to federally authorised clinical research programs. The Schedule III rescheduling dramatically expands permissible US cannabis research.

🏦

Immediate

Institutional Capital Access

Federal DEA registration changes the risk profile for institutional investors. Registered operators can access capital at normal financial institution terms.

🏢

Ongoing

M&A Valuation Premium

DEA registration, clean compliance records, and pharmaceutical-grade SOP infrastructure are the three assets most valued by strategic acquirers entering the US medical cannabis market.

Ready to proceed?

Let’s scope your engagement.

30-minute call. We apply the safe harbour matrix to your SOP library and tell you exactly what needs to be written. No surprises.